Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Sabra Healthcare REIT, Inc. (SBRA) had Return on Tangible Equity of 5.64% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$774.63M
Net Income	$155.61M
Cost of Goods Sold	--
Gross Profit	$774.63M
Operating Expenses	$518.09M
Operating Income	$256.55M
Non-Operating Income/Expense	$-103.13M
Pre-Tax Income	$153.42M
Normalized Pre-Tax Income	$156.94M
Income after Taxes	$151.58M
Income from Continuous Operations	$155.51M
Consolidated Net Income/Loss	$155.51M
Normalized Income after Taxes	$155.14M
EBIT	$256.55M
EBITDA	$443.54M
Weighted-Average Shares Outstanding (Basic)	241.31M
Weighted-Average Shares Outstanding (Diluted)	244.50M
Earnings per Share (EPS) (Basic)	$0.64
Earnings per Share (EPS) (Diluted)	$0.64
Balance Sheet Financials
Current Assets	$512.24M
Property, Plant, and Equipment	$4.69B
Long-Term Assets	$4.98B
Total Assets	$5.49B
Current Liabilities	$119.33M
Long-Term Debt	$2.53B
Long-Term Liabilities	$2.53B
Total Liabilities	$2.67B
Common Equity	$2.82B
Tangible Shareholders Equity	$2.76B
Shareholders Equity	$2.82B
Common Shares Outstanding	251.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$348.61M
Cash Flow from Investing Activities	$-377.96M
Cash Flow from Financial Activities	$40.76M
Beginning Cash	$66.34M
End Cash	$78.14M
Increase/Decrease in Cash	$11.80M
Stock-Based Compensation	$11.36M
Common Stock Dividends Paid	$-289.50M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	--
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	0.90
Gross Margin	--
Operating Margin	33.12%
EBIT Margin	33.12%
EBITDA Margin	57.26%
Pre-Tax Profit Margin	19.81%
Profit Margin	20.09%
Free Cash Flow	$-57.20M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	--
Receiveable Turnover	--
Days Sales in Receivables	--
Return on Equity	5.51%
Return on Tangible Equity	5.64%
Return on Assets	2.83%
Return on Investments	2.91%
Book Value Per Share	$11.22
Free Cash Flow per Share	$-0.23
Operating Cash Flow per Share	$1.43

Data from Zacks Investment Research, Inc.